Research Analysts’ updated eps estimates for Monday, October 23rd:

AMAG Pharmaceuticals (NASDAQ:AMAG) had its hold rating reaffirmed by analysts at Janney Montgomery Scott.

Aptose Biosciences (NASDAQ:APTO) (TSE:APS) had its buy rating reissued by analysts at Roth Capital. The firm currently has a $5.00 target price on the stock.

Actinium Pharmaceuticals (NYSEMKT:ATNM) had its buy rating reaffirmed by analysts at Roth Capital. The firm currently has a $6.00 target price on the stock.

BP plc (LON:BP) had its sector performer rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 500 ($6.64) price target on the stock.

Instinet assumed coverage on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH). The firm issued a buy rating and a $57.00 target price on the stock.

Piper Jaffray Companies started coverage on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH). They issued an overweight rating and a $35.00 target price on the stock.

Nomura assumed coverage on shares of Deciphera Pharmaceuticals (NASDAQ:DCPH). Nomura issued a buy rating on the stock.

Dover Corporation (NYSE:DOV) had its hold rating reaffirmed by analysts at SunTrust Banks, Inc.. They currently have a $96.00 price target on the stock.

Fibria Celulose (NYSE:FBR) had its neutral rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The).

GlaxoSmithKline plc (LON:GSK) had its buy rating reissued by analysts at Beaufort Securities. The firm currently has a GBX 1,800 ($23.92) price target on the stock.

Lennox International (NYSE:LII) had its buy rating reiterated by analysts at Cowen and Company. They currently have a $190.00 price target on the stock. The analysts wrote, “Q3 EPS netted above Street estimates that had dropped materially post the Sept.””

Micron Technology (NASDAQ:MU) had its buy rating reissued by analysts at Citigroup Inc..

Micron Technology (NASDAQ:MU) had its outperform rating reaffirmed by analysts at Macquarie. They currently have a $50.00 price target on the stock, up from their previous price target of $42.00.

Royal Dutch Shell Plc (LON:RDSB) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a GBX 2,500 ($33.22) price target on the stock.

Southern Copper Corporation (NYSE:SCCO) had its buy rating reiterated by analysts at FBR & Co.

Seagate Technology PLC (NASDAQ:STX) had its sector perform rating reiterated by analysts at FBN Securities. They currently have a $40.00 target price on the stock, up from their previous target price of $32.00.

Roth Capital initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS). They issued a neutral rating and a $15.00 price target on the stock.

TESARO (NASDAQ:TSRO) had its neutral rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $117.00 target price on the stock.

Receive News & Ratings for AMAG Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMAG Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.